文献速递头颈介入US

超声引导下细针穿刺细胞学与粗针活检诊断喉及下咽肿物的可行性与诊断效能

Percutaneous Ultrasound-Guided Fine-Needle Aspiration Cytology and Core-Needle Biopsy for Laryngeal and Hypopharyngeal Masses.
PubMed 文献 · Korean J Radiol · 2020-11-30

单中心前瞻性病例系列纳入28例喉镜下高度可疑喉及下咽肿物患者,评估局麻下超声引导细针穿刺细胞学/粗针活检的可行性。26例(92.9%)超声识别肿物,25例(96.2%)操作成功,24例(96.0%)获得明确结果,无严重并发症。作者认为该技术在合适指征下可作为一线诊断方式以避免全麻和直接喉镜活检相关并发症。

要点

  • 超声可识别92.9%(26/28)的喉及下咽肿物,操作成功率为96.2%(25/26)。
  • 操作成功者中96.0%(24/25)获得明确病理结果,包括23例鳞状细胞癌和1例良性肿物。
  • 仅2例(7.7%)出现轻微亚临床血肿,无严重并发症。

关键影像表现/征象

  • 28例接受超声检查的患者中26例(92.9%)识别出喉及下咽肿物。
  • 26例中25例(96.2%)成功完成超声引导细针穿刺细胞学/粗针活检,1例(3.8%)未能靶向肿物。
  • 超声操作导致2例(7.7%)轻微亚临床血肿,无严重并发症。

诊断标准与关键数值

  • 25例操作成功者中24例(96.0%)获得明确结果,包括23例鳞状细胞癌和1例良性肿物。
  • 1例细针穿刺细胞学显示不典型细胞,需追加直接喉镜活检确诊鳞状细胞癌。

临床应用与阅片要点

  • 对喉镜下高度可疑喉及下咽肿物且肿物累及或毗邻会厌前间隙、声门旁间隙、梨状窦和/或声门下区者,可考虑局麻下行超声引导细针穿刺细胞学/粗针活检。
  • 26例接受超声引导细针穿刺细胞学/粗针活检者从初诊至病理诊断时间为7.8天;24例最终确诊鳞状细胞癌者从初诊至开始治疗时间为25.2天。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the feasibility and diagnostic performance of ultrasound (US)-guided fine-needle aspiration cytology and core-needle biopsy (US-FNAC/CNB) for the diagnosis of laryngo-hypopharyngeal masses.

MATERIALS AND METHODS: This was a single-center prospective case series. From January 2018 to June 2019, we initially enrolled 40 patients with highly suspicious laryngo-hypopharyngeal masses on laryngoscopic examinations. Of these, 28 patients with the mass involving or abutting the pre-epiglottic, paraglottic, pyriform sinus, and/or subglottic regions were finally included. These patients underwent US examinations with/without subsequent US-FNAC/CNB under local anesthesia for evaluation of the laryngo-hypopharyngeal mass.

RESULTS: Of the 28 patients who underwent US examinations, a laryngo-hypopharyngeal mass was identified in 26 patients (92.9%). US-FNAC/CNB was performed successfully in 25 of these patients (96.2%), while the procedure failed to target the mass in 1 patient (3.8%). The performance of US caused minor subclinical hematoma in 2 patients (7.7%), but no major complications occurred. US-FNAC/CNB yielded conclusive results in 24 (96.0%) out of the 25 patients with a successful procedure, including 23 patients with squamous cell carcinoma (SCC) and 1 patient with a benign mass. In one patient with atypical cells in US-FNAC, additional direct laryngoscopic biopsy (DLB) was required to confirm SCC. Among the 26 patients who received US-FNAC/CNB, the time from first visit to pathological diagnosis was 7.8 days. For 24 patients finally diagnosed with SCC, the time from first visit to the initiation of treatment was 25.2 days. The mean costs associated with US-FNAC/CNB was $272 under the Korean National Health Insurance Service System.

CONCLUSION: US-FNAC/CNB for a laryngo-hypopharyngeal mass is technically feasible in selected patients, providing good diagnostic performance. This technique could be used as a first-line diagnostic modality by adopting appropriate indications to avoid general anesthesia and DLB-related complications.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Ahn D, Lee GJ, Sohn JH, et al. Percutaneous Ultrasound-Guided Fine-Needle Aspiration Cytology and Core-Needle Biopsy for Laryngeal and Hypopharyngeal Masses. Korean J Radiol. 2020. PMID: 33289361. doi:10.3348/kjr.2020.0396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。